7
total announcements
VAISHALI.NS · 15 min delayed
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming that the said regulation is not applicable to the company for the quarter ended on 30th June 2026.
Vaishali Pharma Limited
Vaishali Pharma Limited has held a board meeting on July 08, 2026, but no specific outcomes or decisions have been disclosed.
Vaishali Pharma Limited
Vaishali Pharma Limited has submitted the Exchange a copy Scrutinizer's report of Postal Ballot. The company has informed the Exchange regarding voting results for the re-appointment of Mr. Pratik Vikram Jakhelia, Mr. Atul Arvind Vasani, and Mrs. Jagruti Vasani as Independent Director, Managing Director, and Whole-Time Director respectively. All resolutions were passed with over 99% approval.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange about the allotment of 45,37,865 equity shares at an issue price of Rs. 20 per share on a preferential basis to Kesar Pharma Limited for consideration other than cash, as discharge of the non-cash consideration for the subscription of 26.95% of the proposed total issued, subscribed and paid-up equity share capital of Kesar Pharma Limited.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange regarding allotment of 45,37,865 securities pursuant to Preferential Issue at its meeting held on July 03, 2026.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 02, 2026. The Board has approved an increase in Authorised Share Capital from INR. 27,00,00,000 to INR. 29,00,00,000, and deferred the proposal relating to the Issue and Allotment of 61,23,000 equity shares.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to consideration of Un-audited Financial Result for the First Quarter Ended 30th June, 2026.